I'm not sure I see the logic of this at all.
(1) If Fuji don't want to proceed then all they have to do is say so.
(2) In numerous presentations, Fuji has stated their prognosis and ambitions with Cymerus technology
(3) Even without Fuji there are pipelines ahead for further development in P2 trials, funded or otherwise, which as standalone features would make CYP an attractive proposition.
I'm not a major stakeholder in this technology but bought sufficient at 30 - 40 cents to make taking a decent profit now quite plausible - but I'm not about to do that. To my way of thinking, although clearly we aren't being told the whole story - something is afoot.
Good luck whatever you decide.
I'm not sure I see the logic of this at all. (1) If Fuji don't...
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.5¢ | $5.375K | 25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27580 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 15135 | 2 |
View Market Depth
| Last trade - 12.20pm 29/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
